2/1/23 21:41 | 2/1/23 | RUBY | Rubius Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Cagnoni Pablo J | MA | D | | S | -2 | 0.2500 | 0 | -8 | -11 | 66 | D | | | | | | | | | | | | | | |
1/31/23 21:51 | 1/29/23 | RUBY | Rubius Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Cagnoni Pablo J | MA | D | | M.dm | 0 | 0.00 | 0 | 46 | 164 | 75 | D | | | | | | | | | | | | | | |
1/31/23 21:51 | 1/31/23 | RUBY | Rubius Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Cagnoni Pablo J | MA | D | | S.d | -2 | 0.2410 | 0 | -7 | -9 | 75 | D | | | | | | | | | | | | | | |
2/1/22 21:20 | 1/29/22 | RUBY | Rubius Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Cagnoni Pablo J | MA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 21 | 149 | 36 | D | | | | | | | | | | | | | | |
2/1/22 21:20 | 2/1/22 | RUBY | Rubius Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Cagnoni Pablo J | MA | DO | CEO,P | S.d | -44 | 6.57 | 0 | -7 | -16 | 36 | D | | | | | | | | | | | | | | |
4/15/20 17:14 | 4/14/20 | RUBY | Rubius Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Cagnoni Pablo J | MA | DO | CEO,P | P | 99 | 4.70 | 0 | 21 | New | 21 | D | | | | | | | | | | | | | | |
11/21/19 16:07 | 11/19/19 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Cagnoni Pablo J | MA | D | | M.d | 42 | 5.59 | 0 | 8 | | 0 | D | | | | | | | | | | | | | | |
11/21/19 16:07 | 11/19/19 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Cagnoni Pablo J | MA | D | | S.d | -465 | 62.00 | 0 | -8 | -100 | 0 | D | | | | | | | | | | | | | | |
11/13/19 16:30 | 11/12/19 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Cagnoni Pablo J | MA | D | | M.d | 42 | 5.59 | 0 | 8 | | 0 | D | | | | | | | | | | | | | | |
11/13/19 16:30 | 11/12/19 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Cagnoni Pablo J | MA | D | | S.d | -413 | 55.00 | 0 | -8 | -100 | 0 | D | | | | | | | | | | | | | | |
11/1/19 18:35 | 10/30/19 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Cagnoni Pablo J | MA | D | | M.d | 42 | 5.59 | 0 | 8 | | 0 | D | | | | | | | | | | | | | | |
11/1/19 18:35 | 10/30/19 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Cagnoni Pablo J | MA | D | | S.d | -390 | 52.00 | 0 | -8 | -100 | 0 | D | | | | | | | | | | | | | | |
7/5/18 18:25 | 7/3/18 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Cagnoni Pablo J | MA | D | | M.dm | 42 | 5.59 | 0 | 8 | | 0 | D | | | | | | | | | | | | | | |
7/5/18 18:25 | 7/3/18 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Cagnoni Pablo J | MA | D | | S.dm | -465 | 62.00 | 0 | -8 | -100 | 0 | D | | | | | | | | | | | | | | |
3/20/09 16:58 | 3/20/09 | ALTH | Allos Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Cagnoni Pablo J | CO | O | SVP,Chie | S | -41 | 6.63 | 3 | -6 | -7 | 87 | | | | | | | | | | 4 | 18 | -3 | 19 | 21 | 20 |
3/20/08 18:06 | 3/20/08 | ALTH | Allos Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Cagnoni Pablo J | CO | O | SVP,Chie | S | -32 | 5.29 | 2 | -6 | -8 | 69 | D | 53 | -15 | 19 | -15 | -20 | -5 | 5 | 2 | 18 | 22 | 16 | 22 | 42 | 26 |
8/13/04 12:35 | 8/12/04 | ALTH | Allos Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Cagnoni Pablo J | CO | H | Former V | S.d | -3 | 1.95 | 1 | -1 | -100 | 0 | D | -78 | -23 | -50 | -3 | -10 | 15 | -7 | 10 | 0 | -9 | 15 | 6 | 20 | 31 |
7/2/04 12:11 | 6/30/04 | ALTH | Allos Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Cagnoni Pablo J | CO | O | VP of Cl | P.d | 3 | 1.91 | 2 | 1 | New | 1 | D | -76 | -25 | -39 | -55 | 13 | -7 | -3 | -4 | 1 | -7 | -25 | -1 | 7 | 0 |
5/18/04 15:55 | 5/12/04 | ALTH | Allos Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Cagnoni Pablo J | CO | O | VP of Cl | S.d | -4 | 2.03 | 6 | -2 | -100 | 0 | D | -72 | -8 | -26 | -55 | -58 | -59 | -12 | 2 | -3 | -15 | 7 | -17 | 8 | 8 |
1/2/04 11:56 | 12/31/03 | ALTH | Allos Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Cagnoni Pablo J | CO | O | VP of Cl | P | 3 | 2.48 | 3 | 1 | 90 | 2 | D | -41 | -52 | 22 | 17 | 28 | 22 | 17 | 6 | 2 | 1 | -2 | 35 | -39 | -33 |